In vivo validation of Diagnodent and Vista proof devices vs ICDAS clinical criteria on incipient carious lesions in adults.
Clinical study
Diagnodent
ICDAS
In vivo
Incipient caries
Vista proof
Journal
Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
09
12
2020
revised:
25
02
2021
accepted:
05
03
2021
pubmed:
13
3
2021
medline:
1
7
2021
entrez:
12
3
2021
Statut:
ppublish
Résumé
This study aimed to validate the in vivo performance of Diagnodent and Vista proof devices with ICDAS clinical criteria on incipient carious lesions in adults. A total of 44 adult patients with 230 incipient occlusal caries took part in the present study. These patients were assessed for caries with ICDAS clinical criteria, and then they were examined with Diagnodent pen™ (DP) and Vista proof™ (VP) fluorescence devices. Sensitivity, specificity accuracy, and ICC agreement between devices with ICDAS criteria, which served as a gold standard, were evaluated. Regarding the caries diagnostic devices, sensitivity and specificity found 0,61 and 0,51 for DP, and 0,64 and 0,54 for VP, respectively. The different detection methods showed no differences in diagnostic capacity (Az values) each other, and ICC values with ICDAS criteria were calculated low. DP and VP do not contribute to incipient occlusal carious lesions' better detective ability compared with visual ICDAS clinical criteria. The DP and VP devices presented no differences in diagnostic ability and measured lesion depth concerning the visual examination.
Identifiants
pubmed: 33711531
pii: S1572-1000(21)00078-8
doi: 10.1016/j.pdpdt.2021.102252
pii:
doi:
Substances chimiques
Photosensitizing Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102252Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.